215 related articles for article (PubMed ID: 16201850)
21. In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.
Ohsugi T; Horie R; Kumasaka T; Ishida A; Ishida T; Yamaguchi K; Watanabe T; Umezawa K; Urano T
Carcinogenesis; 2005 Aug; 26(8):1382-8. PubMed ID: 15831528
[TBL] [Abstract][Full Text] [Related]
22. Anti-proliferative activity of oversulfated fucoidan from commercially cultured Cladosiphon okamuranus TOKIDA in U937 cells.
Teruya T; Konishi T; Uechi S; Tamaki H; Tako M
Int J Biol Macromol; 2007 Aug; 41(3):221-6. PubMed ID: 17433432
[TBL] [Abstract][Full Text] [Related]
23. Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells.
Mori N; Yamada Y; Hata T; Ikeda S; Yamasaki Y; Tomonaga M; Yamamoto N
Biochem Biophys Res Commun; 2001 Apr; 282(5):1110-3. PubMed ID: 11302729
[TBL] [Abstract][Full Text] [Related]
24. Activation of PKC-δ in HTLV-1-infected T cells.
Mori N; Ishikawa C; Senba M
Int J Oncol; 2015 Apr; 46(4):1609-18. PubMed ID: 25625567
[TBL] [Abstract][Full Text] [Related]
25. FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells.
Ishikawa C; Mori N
Invest New Drugs; 2022 Apr; 40(2):245-254. PubMed ID: 34698964
[TBL] [Abstract][Full Text] [Related]
26. Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients.
Li HC; Yashiki S; Sonoda J; Lou H; Ghosh SK; Byrnes JJ; Lema C; Fujiyoshi T; Karasuyama M; Sonoda S
Jpn J Cancer Res; 2000 Jan; 91(1):34-40. PubMed ID: 10744042
[TBL] [Abstract][Full Text] [Related]
27. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.
Dewan MZ; Uchihara JN; Terashima K; Honda M; Sata T; Ito M; Fujii N; Uozumi K; Tsukasaki K; Tomonaga M; Kubuki Y; Okayama A; Toi M; Mori N; Yamamoto N
Blood; 2006 Jan; 107(2):716-24. PubMed ID: 16174765
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
[TBL] [Abstract][Full Text] [Related]
29. Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia.
Tsumuraya T; Ishikawa C; Machijima Y; Nakachi S; Senba M; Tanaka J; Mori N
Biochem Pharmacol; 2011 Mar; 81(6):713-22. PubMed ID: 21219881
[TBL] [Abstract][Full Text] [Related]
30. N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.
Darwiche N; Hatoum A; Dbaibo G; Kadara H; Nasr R; Abou-Lteif G; Bazzi R; Hermine O; de Thé H; Bazarbachi A
Leukemia; 2004 Mar; 18(3):607-15. PubMed ID: 14712289
[TBL] [Abstract][Full Text] [Related]
31. YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cells.
Sasaki R; Ito S; Asahi M; Ishida Y
Leuk Res; 2015 Dec; 39(12):1473-9. PubMed ID: 26547260
[TBL] [Abstract][Full Text] [Related]
32. Cell death induced by dorsomorphin in adult T-cell leukemia/lymphoma is AMPK-independent.
Aikawa A; Kozako T; Uchida Y; Yoshimitsu M; Ishitsuka K; Ohsugi T; Honda SI
FEBS J; 2020 Sep; 287(18):4005-4015. PubMed ID: 32027454
[TBL] [Abstract][Full Text] [Related]
33. MALT-1 as a novel therapeutic target for adult T-cell leukemia.
Ishikawa C; Mori N
Eur J Haematol; 2020 Oct; 105(4):460-467. PubMed ID: 32574386
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas.
Darwiche N; Sinjab A; Abou-Lteif G; Chedid MB; Hermine O; Dbaibo G; Bazarbachi A
Int J Cancer; 2011 Aug; 129(4):993-1004. PubMed ID: 21064094
[TBL] [Abstract][Full Text] [Related]
36. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
Matsuda T; Almasan A; Tomita M; Uchihara JN; Masuda M; Ohshiro K; Takasu N; Yagita H; Ohta T; Mori N
J Virol; 2005 Feb; 79(3):1367-78. PubMed ID: 15650163
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor activity of fucoidan is mediated by nitric oxide released from macrophages.
Takeda K; Tomimori K; Kimura R; Ishikawa C; Nowling TK; Mori N
Int J Oncol; 2012 Jan; 40(1):251-60. PubMed ID: 21874230
[TBL] [Abstract][Full Text] [Related]
38. Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro.
Tomita M; Tanaka Y; Mori N
Int J Cancer; 2010 Oct; 127(7):1584-94. PubMed ID: 20091867
[TBL] [Abstract][Full Text] [Related]
39. Anti-adult T-cell leukemia effects of Bidens pilosa.
Nakama S; Ishikawa C; Nakachi S; Mori N
Int J Oncol; 2011 Apr; 38(4):1163-73. PubMed ID: 21318218
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
Ishitsuka K; Ikeda R; Utsunomiya A; Uozumi K; Hanada S; Suzuki S; Takeuchi S; Takatsuka Y; Takeshita T; Ohno N; Arima T
Leuk Lymphoma; 2002 May; 43(5):1107-14. PubMed ID: 12148893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
